Kyowa Kirin Co., Ltd.

Kyowa Kirin Co., Ltd. has shown a significant intraday increase on March 6, 2026, despite facing a notable decline over the past week and year-to-date. The company, operating in the Pharmaceuticals & Biotechnology sector, has a strong balance sheet and a low debt-to-equity ratio, but profits have decreased substantially.

Kyowa Kirin Co., Ltd. saw a significant stock decline today, contrasting with the broader market. Over the past week and month, the stock has experienced notable decreases. Despite these challenges, the company maintains a low debt profile and strong cash position, supporting its financial stability.

Kyowa Kirin Co., Ltd. faced notable stock volatility, reaching an intraday low of JPY 2,231.00. The company has experienced significant declines over various timeframes, including a year-to-date drop of 11.71%. Despite these challenges, it maintains a market capitalization of JPY 1,349,304 million and a low debt profile.

Kyowa Kirin Co., Ltd. has shown strong stock performance, achieving a notable increase on February 24, 2026, despite a declining market. The company has demonstrated solid gains over the past week and month, while maintaining a low debt profile and strong financial health, with a significant market capitalization.